Ultrastructure of immediate microvascular lung injury induced by bacterial endotoxin in the isolated, no-deficient lung perfused with full blood

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 4, 2005, Pages 47-64

  Chlopicki, S ^a   Walski, M ^b,c   Bartus, J B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bacterial endotoxin; Endothelium; Isolated blood perfused lung; Lung injury; NO

Indexed keywords

CELL PROTEIN; ENDOTOXIN; LIPID; LIPOPOLYSACCHARIDE; MYELIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SURFACTANT;

AIRWAY CONSTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CELL SUBPOPULATION; CELL TYPE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; ERYTHROCYTE; ESCHERICHIA COLI; HOST RESISTANCE; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG INJURY; LUNG SEQUESTRATION; LUNG VASOCONSTRICTION; MICROVASCULATURE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHYLOGENY; PROTEIN DEGRADATION; RAT; REPERFUSION INJURY; THROMBOCYTE; ULTRASTRUCTURE;

ANIMALS; ANOXIA; BACTERIAL INFECTIONS; BLOOD PRESSURE; BLOOD-AIR BARRIER; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; LUNG; LYSINE; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORGAN SIZE; PERFUSION; PULMONARY CIRCULATION; PULMONARY EDEMA; RATS; RATS, WISTAR; TIDAL VOLUME; VASOCONSTRICTION; VENOUS PRESSURE;

EID: 31344432979     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Thiemermann C. Nitric oxide and septic shock. Gen Pharmacol 1997; 29: 159-166.
2. Kirkeboen KA, Strand OA. The role of nitric oxide in sepsis - an overview. Acta Anaesthesiol Scand 1999; 43: 275-288.
3. Spain DA, Wilson MA, Garrison RN. Nitric oxide synthase inhibition exacerbates sepsisinduced renal hypoperfusion. Surgery 1994; 116: 322-330.
4. Offner PJ, Robertson FM, Pruitt BA, Jr. Effects of nitric oxide synthase inhibition on regional blood flow in a porcine model of endotoxic shock. J Trauma 1995; 39: 338-343.
5. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, Simmons RL. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxaemia. Crit Care Med 1992; 20: 1568-1574.
6. Laszlo F, Whittle BJ, Moncada S. Time-dependent enhancement or inhibition of endotoxininduced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 1994; 111: 1309-1315.
7. Park JH, Chang SH, Lee KM, Shin SH. Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 1996; 171: 340-345.
8. Gryglewski RJ, Wolkow PP, Uracz W et al. Protective role of pulmonary nitric oxide in the acute phase of endotoxaemia in rats. Circ Res 1998; 82: 819-827.
9. Cobb JP. Use of nitric oxide synthase inhibitors to treat septic shock: the light has changed from yellow to red. Crit Care Med 1999; 27: 855-856.
10. Shultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725.
11. Laszlo F, Whittle BJ, Moncada S. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat. Br J Pharmacol 1995; 115: 498-502.
12. Yamashita T, Kawashima S, Ohashi Y et al. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 2000; 101: 931-937.
13. Chlopicki S, Bartus JB, Walski M, Wolkow PP, Gryglewski RJ. Nitric Oxide - a safequard of pulmonary microcirculation in early endotoxaemia. In Nitric Oxide: Basic Research and Clinical Applications, RJ Gryglewski, P Minuz (eds). Amsterdam, The Netherlands, IOS Press, 2001; 137-148.
14. Uhlig S, Heiny O. Measuring the weight of the isolated perfused rat lung during negative pressure ventilation. J Pharmacol Toxicol Methods 1995;33:147-152.
15. Chlopicki S, Bartus JB, Gryglewski RJ. Biphasic response to lipopolysaccharide from E. coli in the isolated ventilated blood-perfused rat lung. J Physiol Pharmacol 1999; 50: 551-565.
16. Chlopicki S, Bartus JB, Gryglewski RJ. Hypoxic pulmonary vasoconstriction in isolated bloodperfused rat lung; modulation by thromboxane A2, platelet-activating factor, cysteinyl leukotrienes and endothelin-1. Pol J Pharmacol 2002; 54: 433-441.
17. Walski M, Chlopicki S, Celary-Walska R, Frontczak-Baniewicz M. Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope. J Physiol Pharmacol 2002; 53: 713-723.
18. Uhlig S, Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods 1994; 31: 85-94.
19. Chlopicki S, Olszanecki R, Jakubowski A, Lomnicka M, Gryglewski RJ. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2. Pol J Pharmacol 1999; 51: 443-447.
20. Doerschuk CM, Mizgerd JP, Kubo H, Qin L, Kumasaka T. Adhesion molecules and cellular biomechanical changes in acute lung injury: Giles F. Filley Lecture. Chest 1999; 116: 37S-43S.
21. Shibazaki M, Kawabata Y, Yokochi T, Nishida A, Takada H, Endo Y. Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides. Infect Immun 1999; 67: 5186-5191.
22. Olson NC, Hellyer PW, Dodam JR. Mediators and vascular effects in response to endotoxin. Br Vet J 1995; 151: 489-522.
23. Hellewell PG, Henson PM, Downey GP, Worthen GS. Control of local blood flow in pulmonary inflammation: role for neutrophils, PAF, and thromboxane. J Appl Physiol 1991; 70: 1184-1193.
24. Jakubowski A, Olszanecki R, Chlopicki S. Involvement of platelet activating factor in immediate heart response to lipopolysaccharide. J Physiol Pharmacol 2004; 55: 409-421.
25. Coalson JJ, Hinshaw LB, Guenter CA. The pulmonary ultrastructure in septic shock. Exp Mol Pathol 1970; 12: 84-103.
26. Ballermann BJ, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int 1998; 67(suppl): S100-S108.
27. Salvemini D, Korbut R, Anggard E, Vane J. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1990; 87: 2593-2597.
28. Morrison DC, Ulevitch RJ. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol 1978; 93: 526-617.
29. Noguchi K, Matsuzaki T, Shiroma N, Ojiri Y, Sakanashi M. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. Br J Pharmacol 1996; 118: 941-950.
30. Armstead VE, Minchenko AG, Schuhl RA, Hayward R, Nossuli TO, Lefer AM. Regulation of Pselectin expression in human endothelial cells by nitric oxide. Am J Physiol 1997; 273: H740-H746.
31. Coeffier E, Delautier D, Le Couedic JP, Chignard M, Denizot Y, Benveniste J. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. J Leukoc Biol 1990; 47: 234-243.
32. Sala A, Rossoni G, Berti F, Muller-Peddinghaus R, Folco G. Transcellular synthesis of Cys-LT: from isolated cells to complex organ system. Adv Exp Med Biol 1997; 433: 95-98.
33. Pedersen KE, Bochner BS, Undem BJ. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism. J Pharmacol Exp Ther 1997; 281: 655-662.
34. Chlopicki S, Lomnicka M, Gryglewski RJ. Obligatory role of lipid mediators in plateletneutrophil adhesion. Thromb Res 2003; 110: 287-292.
35. Carden D, Xiao F, Moak C, Willis BH, Robinson-Jackson S, Alexander S. Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am J Physiol 1998; 275: H385-H392.
36. Carney DE, Lutz CJ, Picone AL, Gatto LA, Ramamurthy NS, Golub LM, Simon SR, Searles B, Paskanik A, Snyder K, Finck C, Schiller HJ, Nieman GF. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 1999; 100: 400-406.
37. de Nucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endotheliumderived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988; 85: 2334-2338.
38. Gryglewski RJ, Chlopicki S, Uracz W, Marcinkiewicz E. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit 2001; 7: 1-16.
39. Kanwar S, Kubes P. Nitric oxide is an antiadhesive molecule for leukocytes. New Horiz 1995; 3: 93-104.
40. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987; 92: 181-187.
41. Gryglewski RJ, Szczeklik A, Wandzilak M. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl- leucyl-phenylalanine. Biochem Pharmacol 1987; 36: 4209-4213.
42. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92: 3007-3017.
43. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating plateletneutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999; 106: 391-399.
44. Stanley DW. Eicosanoids mediate insect cellular immune reactions to bacterial infections. Adv Exp Med Biol 1997; 433: 359-362.
45. Herring WB, Herion JC, Walker RI, Palmer JG. Distribution and clearance of circulating endotoxin. J Clin Invest 1963; 42: 79-87.